Correlation Between Ravenquest Biomed and Delta 9
Can any of the company-specific risk be diversified away by investing in both Ravenquest Biomed and Delta 9 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ravenquest Biomed and Delta 9 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ravenquest Biomed and Delta 9 Cannabis, you can compare the effects of market volatilities on Ravenquest Biomed and Delta 9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ravenquest Biomed with a short position of Delta 9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ravenquest Biomed and Delta 9.
Diversification Opportunities for Ravenquest Biomed and Delta 9
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Ravenquest and Delta is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ravenquest Biomed and Delta 9 Cannabis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Delta 9 Cannabis and Ravenquest Biomed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ravenquest Biomed are associated (or correlated) with Delta 9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Delta 9 Cannabis has no effect on the direction of Ravenquest Biomed i.e., Ravenquest Biomed and Delta 9 go up and down completely randomly.
Pair Corralation between Ravenquest Biomed and Delta 9
If you would invest 1.26 in Delta 9 Cannabis on September 1, 2024 and sell it today you would lose (0.46) from holding Delta 9 Cannabis or give up 36.51% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Ravenquest Biomed vs. Delta 9 Cannabis
Performance |
Timeline |
Ravenquest Biomed |
Delta 9 Cannabis |
Ravenquest Biomed and Delta 9 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ravenquest Biomed and Delta 9
The main advantage of trading using opposite Ravenquest Biomed and Delta 9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ravenquest Biomed position performs unexpectedly, Delta 9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Delta 9 will offset losses from the drop in Delta 9's long position.Ravenquest Biomed vs. Holloman Energy Corp | Ravenquest Biomed vs. cbdMD Inc | Ravenquest Biomed vs. Evolus Inc | Ravenquest Biomed vs. CV Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies |